Maher Hadaki
Papers
1
Total Citations
17
H-Index
1
About
Maher Hadaki is a thoracic surgeon whose work sits at the critical intersection of advanced oncologic therapy and surgical intervention. His primary research focuses on salvage pulmonary resection for advanced-stage lung cancer, particularly in patients who have undergone treatment with immune checkpoint inhibitors. Hadaki’s most-cited paper, a 2021 case series and literature review, directly addresses the unclear role of salvage thoracic surgery in managing stages IIIb–IV non-small-cell lung cancer after immunotherapy. By presenting a series of nine patients, he provided early, compelling evidence that pulmonary resection can be a viable option in this challenging cohort, offering a potential path to improved outcomes where standard treatments have failed. This work, with 17 citations, has helped shape a nascent but crucial discussion in thoracic oncology. Hadaki’s contributions are notable for bridging the gap between medical and surgical oncology, demonstrating that aggressive surgical salvage can be safely integrated into modern immunotherapy paradigms. His research is particularly valuable for students and clinicians navigating the evolving landscape of lung cancer treatment, where the boundaries of operability are being redefined.
Research Focus
Key Achievements
Top Papers
- 1